PubVisualPubVisual Book a Demo
Resources Blog About Contact Book a 30-Minute Demo →
For Market Access

Value stories they actually sit through.

Your HEOR evidence is strong. PubVisual turns it into a visual story each stakeholder explores from their own angle: budget impact for the payer, outcomes for the committee, the full model for the reviewer.

Same approved evidence · a different first question
Budget impact
Clinical outcomes
Quality of life
Real-world evidence

The story leads with what each stakeholder needs first. The evidence underneath never changes.

The evidence, undelivered
54.9%

US adults receive barely half of the care the evidence recommends.

McGlynn et al · New England Journal of Medicine

The value story exists. It lives in a dossier the size of a phone book.

Committees get the least readable version of your best evidence.

A story nobody can explore is a story nobody retells.

So we made the value story explorable

Evidence that argues for itself.

The dossier becomes an experience: payers and committees explore the outcomes, the comparisons, and the economics on their own terms, at their own depth.

See what we build ↓
Trusted by teams at Roche Pfizer Novartis Moderna Biogen Takeda
The dossier math

Every stakeholder cut is another review.

The model is rigorous and the dossier is complete. But the payer cut, the committee cut, and the pharmacist cut are each a build and a review cycle, so tailoring gets rationed by the review calendar, not by what stakeholders need.

One approved value story changes that math: the payer, the committee, and the reviewer each take their own route through it, and the review you ran covers all of them.

One value story, three doors in
Budget impact firstPayer
Outcomes firstCommittee
Full model firstReviewer
Reviewed once. Explored three ways.
“The payer asked to keep the link. That was new.”
Market Access Lead · Oncology
Book a demo

Bring us your value story.

In 30 minutes we will show you how your own evidence reads as a story each stakeholder explores their way. Built to move through your review, not around it.

Questions

Frequently asked questions

Yes. That is the architecture: one approved value story with different doors in. The payer starts at budget impact, the committee at outcomes, the reviewer at the model, and everyone reaches the same reviewed evidence.

Nothing is dumbed down. The full depth stays available for the reviewer who wants every assumption; the visual story is the way in, not a replacement for the rigor.

Like everything we build: every claim mapped to its approved source, modular, version-controlled, and structured for review inside your existing Veeva workflow. One review covers every stakeholder route.

Yes, and after them. Stakeholders explore it in their own time, and the request-the-dossier nugget is built in for the ones who want everything.

Your approved value dossier or HEOR publication, and whoever owns the review. We map the stakeholder routes and build the story; your process runs once.